Company intelligence / Profile preview

VivoSense

Ownership: Private
Development stage: Other

Overview

VivoSense's software and services are used to develop and validate digital biomarkers and digital clinical endpoints from wearable sensors in regulated global pharma trials, including rare disease, oncology, and CNS trials. The company's platform allows for advanced real-world physiological data collection and analysis, serving as primary and secondary endpoints in clinical research.

Therapeutic areas: OncologyNeurologyOtherRare Diseases
Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on VivoSense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VivoSense.

Explore the full profile